What is Compounded Tirzepatide and Why Does It Target Two Receptors?

What is Compounded Tirzepatide?

Compounded tirzepatide contains the same active ingredient as Mounjaro® and Zepbound® — the newest generation of prescription weight loss medication. At Curve, we offer it at $125/month through FDA-registered compounding pharmacies, making this cutting-edge treatment accessible without the brand-name price tag.

What makes tirzepatide unique is its dual-action mechanism: it activates two hormone receptors instead of one, producing more significant weight loss than older GLP-1 medications alone.

The Dual-Receptor Advantage: GLP-1 + GIP

Tirzepatide is a dual GLP-1 and GIP receptor agonist. This means it mimics two naturally occurring hormones simultaneously:

• GLP-1 (Glucagon-Like Peptide-1) — reduces appetite, slows digestion, and regulates blood sugar
• GIP (Glucose-Dependent Insulinotropic Polypeptide) — enhances insulin secretion, improves fat metabolism, and works alongside GLP-1 to amplify the appetite-suppressing effect

By targeting both receptors, tirzepatide produces a stronger and more comprehensive metabolic response than GLP-1 medications alone — which is why clinical trials show greater average weight loss with tirzepatide compared to semaglutide.

What Results Can You Expect?

In the SURMOUNT-1 clinical trial, patients using tirzepatide lost an average of 20–22% of their body weight over 72 weeks. For a 200 lb person, that's up to 44 lbs of weight loss.

Patients typically notice reduced cravings and appetite within the first few weeks, with progressively stronger effects as the dose is increased over time.

How is it Administered?

Like semaglutide, compounded tirzepatide is given as a once-weekly subcutaneous injection. Curve ships your medication with all supplies included — vials, syringes, needles, and alcohol wipes — delivered discreetly to your door.

Treatment starts at a low dose and is gradually titrated upward under provider supervision to optimize results while minimizing side effects.

Is It Safe?

Tirzepatide has been studied in large clinical trials across tens of thousands of patients. The most commonly reported side effects are mild gastrointestinal symptoms — nausea, reduced appetite, or loose stools — primarily during the initial dose escalation period.

Every Curve patient is assessed by a board-certified provider before starting to confirm tirzepatide is medically appropriate for them.

Ready to Get Started?

Compounded tirzepatide at $125/month includes your provider consultation, prescription, medication, and free discreet shipping. Get started in minutes with our online questionnaire — no video call required.